Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL001070

Drug Information
NameCYC-116    
SynonymsCHEBI:620120; CHEMBL482967; CID6420138; CYC-116, CYC116; Kinome_636; S1171_Selleck; AC1O4WKE; CYC-116; 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine; 2c5t    
CompanyCyclacel    
IndicationAdvanced solid tumoursTerminated in Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
PubChem Compound IDCID 6420138.    
PubChem Substance IDSID 11618518.    
ClinicalTrials.govNCT00530465;    
TargetAurora AInhibitor[1]
Aurora AMultitarget[1]
Aurora BInhibitor[1]
Aurora BMultitarget[1]
Ref 1Nat Rev Drug Discov. 2009 Jul;8(7):547-66.Cell cycle kinases as therapeutic targets for cancer. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543